Long-term Follow-up of Patients Receiving Aprindine
- 1 November 1983
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 143 (11) , 2131-2133
- https://doi.org/10.1001/archinte.1983.00350110117024
Abstract
• Aprindine hydrochloride is an antiarrhythmic agent presently undergoing clinical trials in the United States. Because of the narrow therapeutic-toxic ratio observed for aprindine, the long-term follow-up of these patients is important in determining the potential clinical effectiveness of this drug. In this report we examine our experience with 30 patients with drug-resistant arrhythmias who were discharged receiving aprindine and who were followed up for a mean period of 25 months. (Arch Intern Med 1983;143:2131-2133)This publication has 3 references indexed in Scilit:
- Aprindine treatment of recurrent ventricular tachycardia in patients with mitral valve prolapseAmerican Heart Journal, 1979
- Treatment of recurrent ventricular tachycardia and fibrillation with aprindineThe American Journal of Cardiology, 1977
- Antiarrhythmic Drug Therapy for Sporadic Ventricular Ectopic ArrhythmiasCirculation, 1974